ClinicalTrials.gg
CompletedNCT07741786Updated Oct 6, 2026

PNF Versus Conventional Exercise in Older Women at Increased Risk of Sarcopenia

An interventional study of Conventional Exercise Program and Proprioceptive Neuromuscular Facilitation Exercises in Sarcopenia, sponsored by Uşak University. Completed at 2 sites in Turkey (Türkiye). Open to female participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-10-06.

Sponsored by Uşak University · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 3 years 11 months after the study started (first participant enrolled Aug 2022, registered Jul 2026).
Updated Oct 6, 2026Start date movedPrimary completion moved+6 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
65 Years and older
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 131 studies in Sarcopenia with a site in Turkey — 36 open to participants now, 43 under way, none of them phase 3. Sarcopenia · Turkey.

Enrollment
15th of 34
40 · median 40
Started
2022
with 15 others
No phase
32 of 131
6 open now
Registered
116th of 131
by date

Among the 131 studies in Sarcopenia with a site in Turkey, this one is the 15th largest by enrollment of the 34 interventional ones that give a count, is one of 16 that started in 2022, is one of 32 with no phase, and was the 116th registered.

Sarcopenia

1,334 studies on the registry are indexed under Sarcopenia; 418 are open to participants now.

Browse Sarcopenia studies →

Open to participants now

36 of the 131 studies in Sarcopenia with a site in Turkey are open now. Recruiting first, the newest first:

31 more — sign in →

All 36 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 246 Sarcopenia studies recruiting now, 155 (63%) set no upper age limit and 32 (13%) stop at 75 or younger; 9 take children under 18; 62 take healthy volunteers.

This study: 65 Years and older · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 131 studies in Sarcopenia with a site in Turkey, or all of them as a file.
02

Study summary

Age-related declines in muscle strength and physical performance may impair balance, mobility, and independence in older adults. Exercise may help preserve these functions; however, thethe comparative benefits of PNF-based exercise versus conventional exercise remain unclear in older women who screen positive for sarcopenia risk.

This randomized study compared a PNF-based exercise program with conventional exercise in community-dwelling women aged 65 years or older with SARC-F scores of 4 or higher. Although all participants screened positive for sarcopenia risk, none met the criteria for confirmed sarcopenia according to the revised European Working Group on Sarcopenia in Older People framework (EWGSOP2). Forty participants were randomly allocated to two groups, with 20 participants in each group. Thirty-four participants completed the study and were included in the analysis, with 17 participants in each group.

Both groups followed a 10-week exercise program comprising three sessions per week, with each session lasting approximately 45 minutes. The first three sessions were conducted at the clinic under physiotherapist supervision. The remaining sessions were performed independently at home, with adherence monitored through weekly telephone follow-up.

The conventional exercise program included lower-extremity strengthening, balance training, functional mobility exercises, sit-to-stand practice, gait exercises, and stretching. The PNF-based program incorporated diagonal and multiplanar movement patterns and task-oriented functional movements into conventional therapeutic exercises. Manual contacts, manual resistance, and hands-on facilitation were used only during the first three supervised sessions.

Participants were assessed at baseline and at one and three months after completion of the 10-week program. Outcomes included balance, functional mobility, walking capacity, lower-extremity functional strength, stair performance, falls efficacy, and depressive symptoms. Assessments included the Berg Balance Scale, Timed Up and Go Test, 6-Minute Walk Test, Five Times Sit-to-Stand Test, stair ascent and descent test, Tinetti Falls Efficacy Scale, and 15-item Geriatric Depression Scale.

Read the detailed description

Age-related declines in muscle strength and physical performance may contribute to impaired balance, mobility limitations, and reduced independence. A positive sarcopenia screening result does not establish a diagnosis of sarcopenia. This study focused on community-dwelling older women who screened positive for sarcopenia risk using the SARC-F questionnaire but did not meet EWGSOP2 criteria for confirmed sarcopenia.

The rationale for the study was to investigate whether incorporating proprioceptive neuromuscular facilitation (PNF) principles into a predominantly home-based exercise program provides additional functional benefits compared with conventional therapeutic exercise of comparable duration and frequency.

This prospective, single-center, two-arm randomized study was conducted at the outpatient Physical Medicine and Rehabilitation and Medical Ecology and Hydroclimatology Clinic of Uşak Training and Research Hospital, Uşak, Türkiye. Participants were women aged 65 years or older with SARC-F scores of 4 or higher who could safely participate in the prescribed exercise program. Participants were randomly allocated in a 1:1 ratio using a computer-generated random-number table.

Both groups followed a 10-week program consisting of three approximately 45-minute sessions per week. The first three sessions were supervised by a physiotherapist at the clinic to demonstrate the exercises, correct performance, and prepare participants for independent practice. Subsequent sessions were performed at home, with weekly telephone follow-up to monitor adherence and address participants' questions. Exercise intensity and progression were individualized according to functional capacity and clinical tolerance.

The PNF-based program incorporated diagonal and multiplanar movement patterns, coordinated neuromuscular activation, and task-oriented functional movements into conventional therapeutic exercises. Manual contacts, manual resistance, and hands-on facilitation were restricted to the first three supervised clinic sessions. Home sessions used PNF-derived movement patterns that participants could perform independently.

Participants and treating physiotherapists could not be blinded because of the nature of the interventions. Outcome assessments were performed by a physician who was not involved in delivering the exercise programs.

Assessments were conducted before the intervention and at one and three months after completion of the 10-week program to examine functional changes and their persistence beyond the intervention period. Outcomes covered balance, functional mobility, walking capacity, sit-to-stand and stair performance, falls efficacy, and depressive symptoms.

Forty participants were randomized, and 34 completed the study. Analyses included participants with complete data, without imputation of missing follow-up measurements. The trial was retrospectively registered, and between-group outcome analyses were interpreted as exploratory.

03

Conditions studied

  • Sarcopenia

Browse trials for

Keywords

  • Sarcopenia
  • PNF exercises
  • Balance
  • Fear of falling
  • Resistance exercise
04

Who can participate

The criteria were revised on the registry on Oct 6, 2026. See what changed

Ages eligible
65 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Female sex.
  • Age 65 years or older.
  • SARC-F score of 4 or higher.
  • Ability to participate safely in the prescribed exercise programme.
  • Completion of the baseline assessment.
  • Written .

Exclusion criteria

Exclusion Criteria:

  • musculoskeletal pain, new-onset gait disturbance, or another active condition requiring additional treatment.
  • Parkinson's disease, stroke, multiple sclerosis, vestibular disorders, vertigo, or other major neurological diseases that could affect balance, gait, mobility, or physical performance.
  • Severe musculoskeletal disorders.
  • Uncontrolled cardiovascular disease.
  • Any condition precluding safe participation in the exercise programme.
  • Participation in a regular exercise programme during the preceding six months.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Clinically significant

Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Active comparator
    ARM 1 / Conventional Exercise Group

    Participants in this group received a conventional exercise program including lower-extremity strengthening, balance training, functional mobility exercises, sit-to-stand practice, gait exercises, and stretching. The program comprised three sessions per week for 10 consecutive weeks, with each session lasting approximately 45 minutes. The first three sessions were conducted at the clinic under physiotherapist supervision. The remaining sessions were performed independently at home, with adherence monitored through weekly telephone follow-up. Exercise intensity and progression were individualized according to each participant's functional capacity and clinical tolerance.

    Behavioral: Conventional Exercise Program

  • Experimental
    PNF-Based Exercise Program

    Participants in this group received a proprioceptive neuromuscular facilitation (PNF)-based exercise program. The program emphasized diagonal and multiplanar movement patterns, coordinated neuromuscular activation, and task-oriented functional movements targeting postural control, balance, gait, and lower-extremity performance. The program comprised three sessions per week for 10 consecutive weeks, with each session lasting approximately 45 minutes. The first three sessions were conducted at the clinic under physiotherapist supervision. Manual contacts, manual resistance, and hands-on facilitation techniques were applied only during these supervised sessions. The remaining sessions were performed independently at home using PNF-derived movement patterns taught at the clinic. Adherence was monitored through weekly telephone follow-up. Progression was individualized according to functional improvement.

    Behavioral: Proprioceptive Neuromuscular Facilitation Exercises

Interventions

  • BehavioralConventional Exercise Program

    Participants received a conventional therapeutic exercise program including lower-extremity strengthening, balance training, functional mobility exercises, sit-to-stand practice, gait exercises, and stretching. The program comprised three sessions per week for 10 consecutive weeks, with each session lasting approximately 45 minutes. The first three sessions were conducted at the clinic under physiotherapist supervision. The remaining sessions were performed independently at home, with adherence monitored through weekly telephone follow-up. Exercise intensity and progression were individualized according to each participant's functional capacity and clinical tolerance.

  • BehavioralProprioceptive Neuromuscular Facilitation Exercises

    Participants received proprioceptive neuromuscular facilitation exercises program. The PNF intervention included diagonal movement patterns, proprioceptive stimulation, coordinated neuromuscular activation, manual resistance, and task-oriented functional movement patterns designed to improve postural control, balance, gait, and lower-extremity functional performance. The program was performed three days per week for 10 consecutive weeks, with each session lasting approximately 45 minutes.Manual contacts, manual resistance, and hands-on facilitation techniques were applied only during the first three supervised clinic sessions. The remaining sessions were performed independently at home using PNF-derived movement patterns taught at the clinic. Adherence was monitored through weekly telephone follow-up.

    Also known as: PNF Exercises

06

What researchers measure

Primary outcomes

  1. Change in Berg Balance Scale score

    Balance function was assessed using the Berg Balance Scale. Scores were measured at baseline, at the first-month assessment, and at the third-month assessment after completion of the 10-week exercise programme. Changes over time and differences between the groups were analyzed.

    Time frame: Baseline and 1 and 3 months after completion of the 10-week exercise programm

Secondary outcomes

  1. Change in Tinetti Falls Efficacy Scale score

    Description: Fear of falling was assessed using the Tinetti Falls Efficacy Scale. Scores were measured at baseline, at the first-month assessment, and at the third-month assessment after completion of the 10-week exercise programme. Changes over time and differences between the groups were analyzed.

    Time frame: Baseline, 1 month, and 3 months after completion of the 10-week exercise programme

  2. Change in Timed Up and Go Test performance

    Description: Functional mobility and dynamic balance were assessed using the Timed Up and Go Test. Completion time were measured at baseline, at the first-month assessment, and at the third-month assessment after completion of the 10-week exercise programme. Changes over time and differences between the groups were analyzed. Lower completion times indicated better functional mobility. Changes over time and differences between the groups were analyzed.

    Time frame: Baseline and 1 and 3 months completion of the 10-week exercise programme

  3. Change in 6-Minute Walk Test distance

    Description: Walking capacity was assessed using the 6-Minute Walk Test. Walking distance, measured in meters, was recorded at baseline, at the first-month assessment, and at the third-month assessment after completion of the 10-week exercise programme. Greater distances indicated better walking capacity. Changes over time and differences between the groups were analyzed.

    Time frame: recorded at baseline, at the first-month assessment, and at the third-month assessment after completion of the 10-week exercise programme.

  4. Change in Five Times Sit-to-Stand Test time

    Description: Lower-extremity functional performance was assessed using the Five Times Sit-to-Stand Test. Completion time, measured in seconds, was recorded at baseline, at the first-month assessment, and at the third-month assessment after t the third-month assessment after completion of the 10-week exercise programme. Lower completion times indicated better functional performance. Changes over time and differences between the groups were analyzed.

    Time frame: Time Frame: Baseline, 1 month, and 3 months after initiation of the 10-week exercise programme.

  5. Change in stair ascent and descent test time

    Description: Functional stair performance was assessed using a stair ascent and descent test. Completion time, measured in seconds, was recorded at baseline, at the first-month assessment, and at the third-month assessment after the 10-week exercise programme. Lower completion times indicated better stair performance. Changes over time and differences between the groups were analyzed.

    Time frame: Time Frame: Baseline, 1 month, and 3 months after the third-month of the 10-week exercise programme.

  6. Change in Geriatric Depression Scale score

    Description: Depressive symptoms were assessed using the Geriatric Depression Scale. Scores were measured at baseline, at the first-month assessment, and at the third-month assessmen the third-month assessment after completion of the 10-week exercise programme. Lower scores indicated fewer depressive symptoms. Changes over time and differences between the groups were analyzed.

    Time frame: Baseline, 1 month, and 3 months after completion of the 10-week exercise programme

07

Study locations

2 sites
  • Facility Name: Uşak Training and Research Hospital
    Uşak, Uşak 64100, Turkey (Türkiye)
  • Usak Training and Research Hospital, Physical Medicine and Rehabilitation Clinic
    Uşak, Turkey (Türkiye)
08

References and documents

Publications

  • • Pereira MP, Gonc¸alves M Proprioceptive Neuromuscular Facilitation Improves Balance and Knee Extensors Strength of Older Fallers. International Scholarly Research Network ISRN Rehabilitation. Volume 2012, Article ID 402612, 7 pages

Individual participant data

Plan to share: No — Individual participant data will not be shared because the ethics approval and informed consent documents did not include permission for external sharing of individual-level data. Aggregate study results may be made available from the corresponding investigator upon reasonable request, subject to institutional and ethical regulations.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2022 to primary completion in May 2023, 9 months.

Of 497 non-industry interventional studies with no phase under Sarcopenia, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 34. This study's 9 months is below that.

Counting every sponsor, half of 509 studies reached it within 18 months; a quarter within 8 and three quarters within 34.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 6, 2026: start Feb 2022 → Aug 2022, primary completion Jul 2022 → May 2023 and completion Aug 2022 → Aug 2023.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 28, 2026
First posted
Aug 3, 2026
StartActual
Aug 1, 2022was Feb 2022
Primary completionActual
May 15, 2023was Jul 2022
CompletionActual
Aug 1, 2023was Aug 2022
Last update
Oct 6, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Start date
Feb 12, 2022→Aug 1, 2022
Oct 6, 2026
Primary completion
Jul 15, 2022→May 15, 2023
Oct 6, 2026
Study completion
Aug 1, 2022→Aug 1, 2023
Oct 6, 2026
Enrollment
34→40
Oct 6, 2026
Eligibility
Sex ALL→FEMALE; 4 inclusion criteria edited, 2 added, 1 removed; 3 exclusion criteria edited, 2 added, 4 removed
What changed in the criteria
Inclusion criteria
  • AddedFemale sex.
  • EditedAdults agedAge 65 years or older.
  • RemovedDiagnosis of sarcopenia according to the European Working Group on Sarcopenia in Older People criteria.
  • AddedSARC-F score of 4 or higher.
  • EditedAbility to participate safely in the prescribed exercise programprogramme.
  • EditedCompletion of the baseline clinical assessment.
  • EditedProvision of writtenWritten informed consent to participate in the study.
Exclusion criteria
  • RemovedParkinson's disease.
  • RemovedPrevious stroke.
  • RemovedMultiple sclerosis.
  • RemovedVestibular disorders or vertigo.
  • AddedClinically significant musculoskeletal pain, new-onset gait disturbance, or another active condition requiring additional treatment.
  • EditedOtherParkinson's disease, stroke, multiple sclerosis, vestibular disorders, vertigo, or other major neurological diseases that could affect balance, gait, mobility, or physical performance.
  • ChangedBefore Severe musculoskeletal disorders that could independently affect balance, gait, mobility, or participation in exercise.Now Severe musculoskeletal disorders.
  • EditedAny medical condition that could precludeprecluding safe participation in the exercise programprogramme.
  • AddedParticipation in a regular exercise programme during the preceding six months.
Oct 6, 2026
Interventions
Arms added: PNF-Based Exercise Program; arms removed: ARM 2/Conventional Exercise Plus PNF Group
Oct 6, 2026
Primary outcomes
1 time frame changed, 1 description edited
What changed in the outcomes
  • Time frameChange in Berg Balance Scale scoreTime Frame: Baseline, 1 month, and 3 months after initiation of the intervention → Baseline and 1 and 3 months after completion of the 10-week exercise programm
  • DescriptionChange in Berg Balance Scale score: how it is measured was reworded
Oct 6, 2026
Secondary outcomes
6 time frame changed, 6 description edited
What changed in the outcomes
  • Time frameChange in Tinetti Falls Efficacy Scale scoreBaseline, 1 month, and 3 months after initiation of the intervention → Baseline, 1 month, and 3 months after completion of the 10-week exercise programme
  • Time frameChange in Timed Up and Go Test performanceTime Frame: Baseline, 1 month, and 3 months after initiation of the intervention → Baseline and 1 and 3 months completion of the 10-week exercise programme
  • Time frameChange in 6-Minute Walk Test distanceTime Frame: Baseline, 1 month, and 3 months after initiation of the intervention → recorded at baseline, at the first-month assessment, and at the third-month assessment after completion of the 10-week exercise programme.
  • Time frameChange in Five Times Sit-to-Stand Test timeTime Frame: Baseline, 1 month, and 3 months after initiation of the intervention → Time Frame: Baseline, 1 month, and 3 months after initiation of the 10-week exercise programme.
  • Time frameChange in stair ascent and descent test timeTime Frame: Baseline, 1 month, and 3 months after initiation of the intervention → Time Frame: Baseline, 1 month, and 3 months after the third-month of the 10-week exercise programme.
  • Time frameChange in Geriatric Depression Scale scoreBaseline, 1 month, and 3 months after initiation of the intervention → Baseline, 1 month, and 3 months after completion of the 10-week exercise programme
  • DescriptionChange in 6-Minute Walk Test distance: how it is measured was reworded
  • DescriptionChange in Five Times Sit-to-Stand Test time: how it is measured was reworded
  • DescriptionChange in Geriatric Depression Scale score: how it is measured was reworded
  • DescriptionChange in Timed Up and Go Test performance: how it is measured was reworded
  • DescriptionChange in Tinetti Falls Efficacy Scale score: how it is measured was reworded
  • DescriptionChange in stair ascent and descent test time: how it is measured was reworded
Oct 6, 2026
Title
PNF Versus Conventional Exercise in Older Women at Increased Risk of Sarcopenia
Oct 6, 2026
Show all 1 update
  1. Oct 6, 2026
    Start date Feb 12, 2022→Aug 1, 2022
    Primary completion Jul 15, 2022→May 15, 2023
    Study completion Aug 1, 2022→Aug 1, 2023
    Enrollment 34→40
    Eligibility Sex ALL→FEMALE; 4 inclusion criteria edited, 2 added, 1 removed; 3 exclusion criteria edited, 2 added, 4 removed
    What changed in the criteria
    Inclusion criteria
    • AddedFemale sex.
    • EditedAdults agedAge 65 years or older.
    • RemovedDiagnosis of sarcopenia according to the European Working Group on Sarcopenia in Older People criteria.
    • AddedSARC-F score of 4 or higher.
    • EditedAbility to participate safely in the prescribed exercise programprogramme.
    • EditedCompletion of the baseline clinical assessment.
    • EditedProvision of writtenWritten informed consent to participate in the study.
    Exclusion criteria
    • RemovedParkinson's disease.
    • RemovedPrevious stroke.
    • RemovedMultiple sclerosis.
    • RemovedVestibular disorders or vertigo.
    • AddedClinically significant musculoskeletal pain, new-onset gait disturbance, or another active condition requiring additional treatment.
    • EditedOtherParkinson's disease, stroke, multiple sclerosis, vestibular disorders, vertigo, or other major neurological diseases that could affect balance, gait, mobility, or physical performance.
    • ChangedBefore Severe musculoskeletal disorders that could independently affect balance, gait, mobility, or participation in exercise.Now Severe musculoskeletal disorders.
    • EditedAny medical condition that could precludeprecluding safe participation in the exercise programprogramme.
    • AddedParticipation in a regular exercise programme during the preceding six months.
    Primary outcomes 1 time frame changed, 1 description edited
    What changed in the outcomes
    • Time frameChange in Berg Balance Scale scoreTime Frame: Baseline, 1 month, and 3 months after initiation of the intervention → Baseline and 1 and 3 months after completion of the 10-week exercise programm
    • DescriptionChange in Berg Balance Scale score: how it is measured was reworded
    Secondary outcomes 6 time frame changed, 6 description edited
    What changed in the outcomes
    • Time frameChange in Tinetti Falls Efficacy Scale scoreBaseline, 1 month, and 3 months after initiation of the intervention → Baseline, 1 month, and 3 months after completion of the 10-week exercise programme
    • Time frameChange in Timed Up and Go Test performanceTime Frame: Baseline, 1 month, and 3 months after initiation of the intervention → Baseline and 1 and 3 months completion of the 10-week exercise programme
    • Time frameChange in 6-Minute Walk Test distanceTime Frame: Baseline, 1 month, and 3 months after initiation of the intervention → recorded at baseline, at the first-month assessment, and at the third-month assessment after completion of the 10-week exercise programme.
    • Time frameChange in Five Times Sit-to-Stand Test timeTime Frame: Baseline, 1 month, and 3 months after initiation of the intervention → Time Frame: Baseline, 1 month, and 3 months after initiation of the 10-week exercise programme.
    • Time frameChange in stair ascent and descent test timeTime Frame: Baseline, 1 month, and 3 months after initiation of the intervention → Time Frame: Baseline, 1 month, and 3 months after the third-month of the 10-week exercise programme.
    • Time frameChange in Geriatric Depression Scale scoreBaseline, 1 month, and 3 months after initiation of the intervention → Baseline, 1 month, and 3 months after completion of the 10-week exercise programme
    • DescriptionChange in 6-Minute Walk Test distance: how it is measured was reworded
    • DescriptionChange in Five Times Sit-to-Stand Test time: how it is measured was reworded
    • DescriptionChange in Geriatric Depression Scale score: how it is measured was reworded
    • DescriptionChange in Timed Up and Go Test performance: how it is measured was reworded
    • DescriptionChange in Tinetti Falls Efficacy Scale score: how it is measured was reworded
    • DescriptionChange in stair ascent and descent test time: how it is measured was reworded
    Interventions Arms added: PNF-Based Exercise Program; arms removed: ARM 2/Conventional Exercise Plus PNF Group
    Title PNF Versus Conventional Exercise in Older Women at Increased Risk of Sarcopenia
    + 3 other changes: verification date, description and design details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07741786
Lead sponsor
Uşak University
Responsible party
Nihal Yilmaz (Assistant Professor, Uşak University) — Principal investigator
First posted
Aug 3, 2026
Start date
Aug 1, 2022
Primary completion
May 15, 2023
Completion
Aug 1, 2023
Last update
Oct 6, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion